24 results
424B3
MKULQ
Molekule Group, Inc.
13 Jul 23
Prospectus supplement
4:42pm
patients. Component failures, manufacturing defects or design flaws could result in an unsafe condition or injury to, or death of, a patient or other … products may have caused or contributed to a death or serious injury, or have malfunctioned and the products or a similar product we market would likely
424B3
f11ihfbq1f1ng3q
20 Dec 22
Prospectus supplement
7:34pm
S-4
7g28kr6vt4j95gna426
19 Dec 22
Registration of securities issued in business combination transactions
11:54am
DRS
bh8x gp65484i8f1i6
9 Nov 22
Draft registration statement
12:00am
424B3
xx2osf6j5plpyoe7
22 Jul 22
Prospectus supplement
9:00am
S-1/A
n3w dhllcixsqdtf
20 Jul 22
IPO registration (amended)
12:04pm
S-1
yzjzmy
11 Jul 22
IPO registration
4:19pm
10-K
ly9gcvxrahmn6c6
1 Apr 22
Annual report
4:39pm
253G1
z5l3wmyt
24 Nov 21
Information omitted from offering circular
5:02pm
DOS/A
hexw9l9ixj p2na
3 Sep 21
Draft offering statement (non-public) (amended)
12:00am
DOS/A
dhaguaa hxcr3l9
3 Sep 21
Draft offering statement (non-public) (amended)
12:00am